RedHill Biopharma Ltd. (NASDAQ:RDHL)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $9.5M
- Net income
- -$9.3M
- Net margin
- -97.5%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $1.1M
- Cash
- $5.2M
Owes more within a year than it holds to pay it.
- Current assets
- $8.6M
- Current liabilities
- $25.6M
- Current ratio
- 0.34
Consumes cash and must keep raising it.
- Operating cash flow
- -$8.2M
- Free cash flow
- -$8.2M
- FCF margin
- -86.0%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 1.8M
- Share growth (1y)
- -23.3%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
RDHL Income Statement
| Fiscal Period | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
| Revenue | 2.04 M | 2.04 M | 2.74 M | 2.74 M | 1.29 M | 1.29 M |
| Revenue Growth (YoY) | 58.59 % | 58.59 % | 382.03 % | 382.03 % | -28.40 % | -64.27 % |
| Cost of Revenue | 803.50 K | 803.50 K | 894.00 K | 894.00 K | 702.00 K | 702.00 K |
| Gross Profit | 1.24 M | 1.24 M | 1.84 M | 1.84 M | 584.00 K | 584.00 K |
| SG&A Expense | 2.94 M | 2.94 M | 3.28 M | 3.28 M | 4.48 M | 4.48 M |
| R&D Expense | 482.00 K | 482.00 K | 464.50 K | 464.50 K | 329.50 K | 329.50 K |
| Operating Expenses | 3.42 M | 3.42 M | 4.92 M | 4.92 M | 4.81 M | 4.81 M |
| Operating Income | -2.19 M | -2.19 M | -3.08 M | -3.08 M | -4.22 M | -4.22 M |
| Pretax Income | -2.07 M | -2.07 M | -2.59 M | -2.59 M | -1.54 M | -1.54 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.07 M | -2.07 M | -2.59 M | -2.59 M | -1.54 M | -1.54 M |
| EPS (Basic) | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 |
| EPS (Diluted) | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 |
| Shares Outstanding | 1.80 M | 1.80 M | 2.58 M | 2.58 M | 2.35 M | 2.35 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.